Role of Cryobiopsy in Diagnosis of Pleural Effusion

NCT ID: NCT03828903

Last Updated: 2021-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-10

Study Completion Date

2021-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the feasibility, size and quality of the specimens obtained by cryoprobe in comparison to those specimens obtained by flexible forceps during medical thoracoscopy in diagnosis of pleural effusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Medical thoracoscopy with single-port-of-entry technique will be performed in the bronchoscopy unit under local anesthesia and conscious sedation using midazolam (2 mg) or pethidin.
* vertical incision will be made with the scalpel (usually near the midaxillary line), through the skin and subcutaneous tissue, appropriate to the size of the trocar to be used, usually of approximately 10 mm, parallel with and in the middle of the selected intercostal space.
* Then the trocar will be inserted until the sudden release of resistance (after passing the costal pleura) is felt.
* Under direct vision with the thoracoscope, introduction of pneumothorax will be performed, and all pleural fluid will be removed, and the pleural cavity will be inspected.
* Suspicious areas will be biopsied through the working channel of the thoracoscope.
* two to six biopsies of a suspicious pleural lesion will establish the diagnosis.

Technique of pleural biopsy using cryotechnique:

* The probe (ERBE Elektromedizin GmbH( Gesellschaft mit beschränkter Haftung) , Germany of 2.4mm) will be placed perpendicular to the surface of the parietal pleura with the tip of the probe extended well beyond the tip of the scope using the marking on the probe and with direct visualization.
* The tip of the cryoprobe will be attached to suspicious part of parietal pleura and activated by footswitch.
* carbon dioxide will be used as the cryogen gas for cryobiopsy
* The frozen tissue is going to be extracted by gently pulling of the probe.
* Freezing will be carried out for 6 to 10 seconds depending on the visual assessment of pleural texture.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pleural Effusion

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cryobiopsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pleural effusion patients

medical thoracoscopy will e performed to patients with pleural effusion and pleural biopsy by forceps ad cryoprobe will be obtained

Group Type EXPERIMENTAL

Cryoprobe

Intervention Type DEVICE

* The probe (ERBE Elektromedizin GmbH; Tubingen, Germany of 2.4mm) will be placed perpendicular to the surface of the parietal pleura with the tip of the probe extended well beyond the tip of the scope using the marking on the probe and with direct visualization.
* The tip of the cryoprobe will be attached to suspicious part of parietal pleura .
* The frozen tissue is going to be extracted by gently pulling of the probe.
* Freezing will be carried out for 6 to 10 seconds depending on the visual assessment of pleural texture.
* The probe with the attached biopsy sample is going to be removed together with the thoracoscope through trocar.
* The biopsy sample will be released from the probe by thawing in the saline.
* The semirigid pleuroscope will be reintroduced through the port and the pleura will be revisualized for bleeding.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cryoprobe

* The probe (ERBE Elektromedizin GmbH; Tubingen, Germany of 2.4mm) will be placed perpendicular to the surface of the parietal pleura with the tip of the probe extended well beyond the tip of the scope using the marking on the probe and with direct visualization.
* The tip of the cryoprobe will be attached to suspicious part of parietal pleura .
* The frozen tissue is going to be extracted by gently pulling of the probe.
* Freezing will be carried out for 6 to 10 seconds depending on the visual assessment of pleural texture.
* The probe with the attached biopsy sample is going to be removed together with the thoracoscope through trocar.
* The biopsy sample will be released from the probe by thawing in the saline.
* The semirigid pleuroscope will be reintroduced through the port and the pleura will be revisualized for bleeding.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- 1. Unilateral moderate or massive exudative pleural effusion patients. 2. Undiagnosed pleural effusion after simple pleural fluid aspiration, cytology or blind (closed) pleural biopsy using Abram's needle.

3\. Age\>18 years old

Exclusion Criteria

1. Transudative pleural effusion.
2. Exudative pleural effusion less than one third of hemithorax.
3. Presence of hemorrhagic diathesis (prothrombin concentration \<50% and platelet count \<80,000/mm 3).
4. Poor performance state (ECOG performance status \>4) as recommended in BTS (British thoracic society) guidelines 2010.
5. Sever uncontrollable cough, hypercapnia and sever respiratory distress.
6. Fibrothorax, excessive pleural adhesion.

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alaa Salah Abd El Ghany

Assistant lecturer, Chest Department and tuberculosis

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Reham M El morshedy, Lecturer

Role: PRINCIPAL_INVESTIGATOR

Assiut University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assuit University hospital

Asyut, , Egypt

Site Status

Alaa Salah Abdel gany

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Chen CH, Cheng WC, Wu BR, Chen CY, Chen WC, Liao WC, Tu CY. Feasibility and Safety of Pleuroscopic Cryobiopsy of the Pleura: A Prospective Study. Can Respir J. 2018 Jan 22;2018:6746470. doi: 10.1155/2018/6746470. eCollection 2018.

Reference Type BACKGROUND
PMID: 29610630 (View on PubMed)

Tousheed SZ, Manjunath PH, Chandrasekar S, Murali Mohan BV, Kumar H, Hibare KR, Ramanjaneya R. Cryobiopsy of the Pleura: An Improved Diagnostic Tool. J Bronchology Interv Pulmonol. 2018 Jan;25(1):37-41. doi: 10.1097/LBR.0000000000000444.

Reference Type BACKGROUND
PMID: 29261578 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cryobiopsy pleural effusion

Identifier Type: -

Identifier Source: org_study_id